Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Invested Capital (2021 - 2025)

Maravai Lifesciences Holdings has reported Return on Invested Capital over the past 5 years, most recently at 0.45% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 0.45% for Q4 2025, down 22.0% from a year ago — trailing twelve months through Dec 2025 was 0.45% (down 22.0% YoY), and the annual figure for FY2025 was 0.33%, down 12.0%.
  • Return on Invested Capital for Q4 2025 was 0.45% at Maravai Lifesciences Holdings, down from 0.29% in the prior quarter.
  • Over the last five years, Return on Invested Capital for MRVI hit a ceiling of 0.5% in Q1 2022 and a floor of 0.46% in Q2 2025.
  • Median Return on Invested Capital over the past 5 years was 0.15% (2023), compared with a mean of 0.11%.
  • Biggest five-year swings in Return on Invested Capital: grew 27bps in 2022 and later plummeted -48bps in 2025.
  • Maravai Lifesciences Holdings' Return on Invested Capital stood at 0.47% in 2021, then fell by -23bps to 0.36% in 2022, then plummeted by -99bps to 0.01% in 2023, then crashed by -4590bps to 0.23% in 2024, then crashed by -93bps to 0.45% in 2025.
  • The last three reported values for Return on Invested Capital were 0.45% (Q4 2025), 0.29% (Q3 2025), and 0.46% (Q2 2025) per Business Quant data.